Our gastrointestinal stromal tumor nomogram is a prediction tool designed to help patients and their physicians calculate the likelihood of tumor recurrence following the complete resection (surgical removal of all cancerous tissue) of the gastrointestinal stromal tumor. It is designed for patients who have not received tyrosine kinase inhibitors before or after surgery.
All results from this tool should be discussed with a physician and understood in the context of each patient’s program of care. Results from the gastrointestinal stromal tumor nomogram are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of gastrointestinal stromal tumor procedures, and validated using external databases from the Mayo Clinic and the Spanish Sarcoma Registry. This tool has also been externally validated by the Singapore General Hospital (see Supporting Publications).
Use our Gastrointestinal Stromal Tumor: Survival Without Recurrence Following Surgery nomogram.